Mittwoch, Juni 22, 2022
StartBiotechnologyNew patent for Deciphera Pharms drug QINLOCK – DrugPatentWatch

New patent for Deciphera Pharms drug QINLOCK – DrugPatentWatch


Copyright © DrugPatentWatch. Initially printed at New patent for Deciphera Pharms drug QINLOCK

Annual Drug Patent Expirations for QINLOCK
Annual Drug Patent Expirations for QINLOCK

Qinlock is a drug marketed by Deciphera Pharms and is included in a single NDA. There are six patents defending this drug.

This drug has forty patent members of the family in twelve international locations.

The generic ingredient in QINLOCK is ripretinib. Extra particulars can be found on the ripretinib profile web page.

For extra data on how DrugPatentWatch may also help together with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com

Make Higher Choices with DrugPatentWatch

» Begin Your Free Trial As we speak «

Copyright © DrugPatentWatch. Initially printed at New patent for Deciphera Pharms drug QINLOCK

RELATED ARTICLES

Most Popular

Recent Comments